Multi-targeted activity against these AML-associated kinases may explain the potency of TAE-684 toward Flt3-ITD+ AML cell proliferation, despite its apparent lack of direct activity against the Flt3-ITD kinase in cells. The gene discussed is FLT3; the disease is acute myeloid leukemia.